Perceived Stress, Resilience, and Wellbeing in Seasoned Isha Yoga Practitioners Compared to Matched Controls During the COVID-19 PandemicRandomized Controlled Trial Published on 2022-07-292022-10-05 Journal: Frontiers in Public Health [Category] 임상, [키워드] Anxiety asked baseline Comparator group Compliance Control COVID-19 COVID-19 infection Depression facilitate foundation groups include information IQR Isha Foundation Matched median meditation Mental mental health pandemic participant Perceived Perceived stress Perceived Stress Scale physical Placebo Practitioner practitioners Primary outcome protocol PSS question questionnaire Randomized recruited Resilience shown significantly higher significantly lower Stress Study participants Weekly wellbeing yoga [DOI] 10.3389/fpubh.2022.813664 PMC 바로가기 [Article Type] Randomized Controlled Trial
An evaluation of the COVID-19 recommendation map identified diverging clinical and public health guidanceResearch article Published on 2022-07-012022-10-05 Journal: Journal of clinical epidemiology [Category] 임상, [키워드] “COVID-19 addressed Analysis applied clinical Cluster Clusters comparable Comparator group coronavirus disease COVID-19 defined Discordance Divergence evaluate evaluated Evidence explicit Factor gateway GRADE Guidance guidelines help Interpretation Intervention objective platform public health recommendations Result setting [DOI] 10.1016/j.jclinepi.2022.03.008 [Article Type] Research article
Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 InfectionSARS-CoV-2 감염에서 혈청 I형 인터페론 수치에 대한 Casirivimab/Imdevimab 치료의 효과Observational Study Published on 2022-06-272022-09-12 Journal: Viruses [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] addition administration Antibody-dependent enhancement Blood level Casirivimab Cohort Comparator group consecutive patient COVID-19 cytokine Dexamethasone early phase Effect enrolled evaluated Hospitalized Hypoxemia IFN-I IFN-α IFN-β Imdevimab immune response immunoassay Infection innate immune response interferon Level on type onset of symptoms Patient patients with SARS-CoV-2 prospective observational study recruited Remdesivir SARS-CoV-2 SARS-COV-2 infection significantly temperature therapeutic effect Treatment Type type I interferon were assessed [DOI] 10.3390/v14071399 PMC 바로가기 [Article Type] Observational Study
Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort studyObservational Study Published on 2022-03-182022-10-05 Journal: BMJ Open [Category] SARS, 임상, [키워드] 95% CI Admission adverse outcome association cohort study Comparator group Control controls COVID-19 death Epidemiology examined healthcare hospitalisation ICU ICU admission individual intensity intensive care Interaction internal medicine lab Mortality nasal swab Observational cohort study outcome over performed positive Positive test receiving SARS-CoV-2 significantly specific effects tested veteran [DOI] 10.1136/bmjopen-2021-058363 PMC 바로가기 [Article Type] Observational Study
Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients고형장기 이식 환자의 코로나19 단일클론항체 치료Article Published on 2022-02-012022-09-11 Journal: Transplant infectious disease : an official journa [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] adverse event adverse events age antibody treatment bamlanivimab biopsy Casirivimab casirivimab-imdevimab circulating viral variant circulating viral variants Comparator group confidence confidence interval coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 symptom COVID-19 symptoms deaths Diabetic diagnosed with COVID-19 eligible emergency department Emergency use authorization Follow-up generally mild high risk High-risk patients Hospitalization Imdevimab infusion interval Intervention IQR kidney kidney transplant liver lung median age median time Mild mild to moderate Mild to moderate COVID-19 Moderate COVID-19 monoclonal monoclonal antibodies monoclonal antibody nine occurred organ Organ transplant outcome Patient patients Ratio receive recipient recipients reduce rejection risk SARS-CoV-2 SARS-CoV-2 spike protein severe coronavirus disease single-center Solid solid organ solid organ transplant SOT Spike protein statistically significant study period the SARS-CoV-2 therapy Transplant treated Treatment two patients Viral Viral variants [DOI] 10.1111/tid.13759 PMC 바로가기 [Article Type] Article
318. Description of Patients Readmitted within 30 Days from COVID-19 HospitalizationPoster Abstracts Published on 2021-11-042022-10-29 Journal: Open Forum Infectious Diseases [Category] COVID-19, [키워드] acute respiratory syndrome addition age BMI center close monitoring co-morbidity Comorbidity Comparator group Complication Coronavirus-2 COVID-19 COVID19 Critical care Day demographics description develop discharge etiology Gender group Hospitalization hyperlipidemia hypertension identify Inc Lilly male median age obese Panel Patient patient population Prevalence readmission reduce Regeneron required Result Retrospective study review risk SARS-CoV-2 single-center state university with COVID-19 [DOI] 10.1093/ofid/ofab466.520 PMC 바로가기 [Article Type] Poster Abstracts
The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled StudiesReview Published on 2021-10-252022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] 95% confidence interval all-cause mortality approach carried Clinical practice Comparator group composed conducted Controlled coronavirus disease COVID-19 COVID-19 patient COVID-19 pneumonia database Efficacy eligible feature heterogeneity inclusion criteria information Meta-analysis moderate nine outcome Patient performed randomized clinical trial RCT RCTs receptor required review SARS-CoV-2 searched severe COVID-19 severe disease subgroup analysis survival odd systematic review TCZ the disease therapeutic therapeutic option Tocilizumab Treatment trial sequential analysis TSA type I [DOI] 10.3390/jcm10214935 PMC 바로가기 [Article Type] Review
Prevalence of SARS-CoV-2 Infection in Children by Antibody Detection in Saliva: Protocol for a Prospective Longitudinal Study (Coro-Buddy)Protocol Published on 2021-10-082022-10-29 Journal: JMIR Research Protocols [Category] COVID-19, [키워드] antibody approach Asymptomatic Blood children Cohort collected Comparator group COVID-19 COVID-19 pandemic Data analysis detection determine disease enrolled Enrollment enzyme-linked immunosorbent epidemiological data Epidemiology Germany Identifier incidence Infants Infection lack longitudinal Mild symptom objective participant polymerase chain Prevalence Prospective recruited recruitment Registration report Result Saliva SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection School Schools Tübingen unique [DOI] 10.2196/27739 PMC 바로가기 [Article Type] Protocol
Risk of hospital admission with covid-19 among teachers compared with healthcare workers and other adults of working age in Scotland, March 2020 to July 2021: population based case-control studyResearch Published on 2021-09-022022-10-28 Journal: The BMJ [Category] COVID-19, Fulltext, SARS, [키워드] 95% confidence interval adjusted age assigned case-control study Comorbidity Comparator group Control Council cumulative death defined Deprivation determine Diagnosis discharge General population had no healthcare worker hospital Hospital admission incidence increased risk intensive care logistic regression model lower risk MOST number of comorbidities objective outcome measure over participant Patient Population positive test result Primary outcome random receiving reference number Result risk SARS-CoV-2 School Scottish setting Sex study period Teaching unique women [DOI] 10.1136/bmj.n2060 PMC 바로가기 [Article Type] Research
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents미국 요양원 거주자들 사이에서 mRNA SARS-CoV-2 백신 접종 후 부작용Article Published on 2021-06-292022-09-11 Journal: Vaccine [Category] SARS, 치료기술, [키워드] Adverse adverse event anaphylaxis association Comparator group COVID-19 dose EHR EHR data Electronic health record Emergency use authorization event events excluded first dose genesis health record MONITOR mRNA mRNA vaccine mRNA vaccines neurologic nursing home outcomes pandemic Prevent problem Record SARS-CoV-2 SARS-CoV-2 mRNA vaccines SARS-CoV-2 pandemic SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose Skilled nursing facilities study cohort the SARS-CoV-2 The United States the vaccine Trial United States vaccination Vaccinations Vaccine Vaccine safety monitoring. [DOI] 10.1016/j.vaccine.2021.05.088 PMC 바로가기 [Article Type] Article